10,000 blood clot patients enrolled in massive Real-World treatment registry
NCT ID NCT03504007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that follows up to 10,000 people who have been diagnosed with a blood clot (deep vein thrombosis or pulmonary embolism) and started blood-thinning medication within 14 days. Researchers at the Mayo Clinic will track how many patients have another clot or a major bleeding event over time. The goal is to see how well standard treatments work in everyday medical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DEEP VEIN THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new device suck out deadly lung clots?
- Could tailored blood thinner dosing prevent strokes in chinese patients?
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
- Simple 5-Step nursing plan could slash deadly clot risk after hip surgery
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm
- Blood test ratio may speed up detection of dangerous lung clots